92 related articles for article (PubMed ID: 27465367)
1. The solvation structure of alprazolam.
Sridhar A; Johnston AJ; Varathan L; McLain SE; Biggin PC
Phys Chem Chem Phys; 2016 Aug; 18(32):22416-25. PubMed ID: 27465367
[TBL] [Abstract][Full Text] [Related]
2. Isolation and structural elucidation of degradation products of alprazolam: photostability studies of alprazolam tablets.
Nudelman NS; Cabrera CG
J Pharm Sci; 2002 May; 91(5):1274-86. PubMed ID: 11977103
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of Alprazolam (Xanax): a review of its crystalline phases and identification, crystallographic characterization, and crystal structure of a new polymorph (form III).
de Armas HN; Peeters OM; Van den Mooter G; Blaton N
J Pharm Sci; 2007 May; 96(5):1114-30. PubMed ID: 17455340
[TBL] [Abstract][Full Text] [Related]
4. Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.
Filippakopoulos P; Picaud S; Fedorov O; Keller M; Wrobel M; Morgenstern O; Bracher F; Knapp S
Bioorg Med Chem; 2012 Mar; 20(6):1878-86. PubMed ID: 22137933
[TBL] [Abstract][Full Text] [Related]
5. Molecular complexes of alprazolam with carboxylic acids, boric acid, boronic acids, and phenols. Evaluation of supramolecular heterosynthons mediated by a triazole ring.
Varughese S; Azim Y; Desiraju GR
J Pharm Sci; 2010 Sep; 99(9):3743-53. PubMed ID: 20665840
[TBL] [Abstract][Full Text] [Related]
6. Solubility and intrinsic dissolution rate of alprazolam crystal modifications.
Laihanen N; Muttonen E; Laaksonen M
Pharm Dev Technol; 1996 Dec; 1(4):373-80. PubMed ID: 9552321
[TBL] [Abstract][Full Text] [Related]
7. Alprazolam is relatively more toxic than other benzodiazepines in overdose.
Isbister GK; O'Regan L; Sibbritt D; Whyte IM
Br J Clin Pharmacol; 2004 Jul; 58(1):88-95. PubMed ID: 15206998
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepam.
DeVane CL; Ware MR; Lydiard RB
Psychopharmacol Bull; 1991; 27(4):463-73. PubMed ID: 1687613
[TBL] [Abstract][Full Text] [Related]
9. Alprazolam--a new triazolobenzodiazepine.
Talmud J; Straughan JL; Robins AH
S Afr Med J; 1984 Aug; 66(8):297-8. PubMed ID: 6147900
[TBL] [Abstract][Full Text] [Related]
10. Absence of food effect on the extent of alprazolam absorption from an orally disintegrating tablet.
Erdman K; Stypinski D; Combs M; Witt P; Stiles M; Pollock S
Pharmacotherapy; 2007 Aug; 27(8):1120-4. PubMed ID: 17655512
[TBL] [Abstract][Full Text] [Related]
11. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
Klein E
J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans.
Leicht G; Mulert C; Eser D; Sämann PG; Ertl M; Laenger A; Karch S; Pogarell O; Meindl T; Czisch M; Rupprecht R
Biol Psychiatry; 2013 Feb; 73(4):337-44. PubMed ID: 23059050
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine receptor number after acute administration of alprazolam and diazepam.
Sethy VH; Harris DW
Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):229-35. PubMed ID: 6122240
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam.
Yuan R; Flockhart DA; Balian JD
J Clin Pharmacol; 1999 Nov; 39(11):1109-25. PubMed ID: 10579141
[TBL] [Abstract][Full Text] [Related]
15. Raman mapping of low-content API pharmaceutical formulations. I. Mapping of Alprazolam in Alprazolam/Xanax tablets.
Sasić S
Pharm Res; 2007 Jan; 24(1):58-65. PubMed ID: 17048116
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of alprazolam.
Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):45-7. PubMed ID: 6135693
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of alprazolam. Therapeutic implications.
Greenblatt DJ; Wright CE
Clin Pharmacokinet; 1993 Jun; 24(6):453-71. PubMed ID: 8513649
[TBL] [Abstract][Full Text] [Related]
18. A controlled clinical trial of alprazolam for the treatment of anxiety.
Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
[TBL] [Abstract][Full Text] [Related]
19. Alprazolam and benzodiazepine dependence.
Sellers EM; Ciraulo DA; DuPont RL; Griffiths RR; Kosten TR; Romach MK; Woody GE
J Clin Psychiatry; 1993 Oct; 54 Suppl():64-75; discussion 76-7. PubMed ID: 8262891
[TBL] [Abstract][Full Text] [Related]
20. Alprazolam compared to clobazam and placebo in anxious outpatients.
Castillo A; Sotillo C; Mariategui J
Neuropsychobiology; 1987; 18(4):189-94. PubMed ID: 2900483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
